The abstract is read at the publisher; the summary is JClub's.
MRI in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) shows characteristic lesion evolution, including frequent T2-lesion resolution and radiologic lag, distinct from MS and AQP4+NMOSD.
- Why it matters: Imaging is central to confirming MOGAD attacks, mapping lesion distribution, and excluding alternatives, yet underrecognized MRI spectra and parameter variability can delay diagnosis and treatment.
- What they did: This review summarizes hallmark MRI features across optic nerve, brain, and spinal cord, aligns them with the 2023 diagnostic criteria, and proposes a standardized acute-attack MRI protocol plus guidance on rebaselining timing.
- The result: Recognizing these imaging dynamics can improve diagnostic accuracy and harmonize research protocols, while the rarity of asymptomatic radiological activity suggests surveillance MRI may have less clinical utility than in MS.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.